Flexion Therapeutics Inc 4/A SEC Filings

Filed On	Filing
12 Mar 2021	Form 4/A: Colella Samuel D, Director Acquired 2,198 shares (Other Transaction)
05 Mar 2019	Form 4/A: Wentworth Kerry, Chief Regulatory Officer Received 3,400 shares by exercise or conversion · Gave up 1,002 shares to cover exercise price or tax ($18.6K)
19 May 2017	Form 4/A: Bodick Neil, Chief Medical Officer Received 6,830 shares by exercise or conversion ($17.2K) · Sold 6,830 shares ($129K)
19 May 2017	Form 4/A: Bodick Neil, Chief Medical Officer Received 5,000 shares by exercise or conversion ($12.6K) · Sold 5,000 shares ($141K)
19 May 2017	Form 4/A: Bodick Neil, Chief Medical Officer Received 5,000 shares by exercise or conversion ($12.6K) · Sold 5,000 shares ($102K)
19 May 2017	Form 4/A: Bodick Neil, Chief Medical Officer Received 4,000 shares by exercise or conversion ($10.1K) · Sold 5,000 shares ($95.8K)
22 Jun 2016	Form 4/A: Mahaffy Patrick J, Director Granted 18,000 Stock Option (Right To Buy)
22 Jun 2016	Form 4/A: Lukatch Heath, Director Granted 12,500 Stock Option (Right to Buy)
22 Jun 2016	Form 4/A: Milinazzo Alan, Director Granted 12,500 Stock Option (Right to Buy)
22 Jun 2016	Form 4/A: Colella Samuel D, Director Granted 12,500 Stock Option (Right to Buy)
22 Jun 2016	Form 4/A: Mahatme Sandesh, Director Granted 12,500 Stock Option (Right to Buy)
22 Jun 2016	Form 4/A: Canute Scott A, Director Granted 12,500 Stock Option (Right to Buy)

Comments